Free Trial
NASDAQ:QDEL

QuidelOrtho (QDEL) Stock Price, News & Analysis

QuidelOrtho logo
$10.74 +0.12 (+1.13%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$10.74 0.00 (0.00%)
As of 11/13/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About QuidelOrtho Stock (NASDAQ:QDEL)

Advanced

Key Stats

Today's Range
$10.28
▼
$11.19
50-Day Range
$10.34
▼
$14.35
52-Week Range
$9.92
▼
$35.58
Volume
2.04 million shs
Average Volume
2.36 million shs
Market Capitalization
$736.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.63
Consensus Rating
Reduce

Company Overview

QuidelOrtho Corporation develops and manufactures diagnostic testing products used in healthcare settings. Its offerings include tests and instruments for immunoassay, molecular diagnostics, clinical chemistry, and transfusion medicine, as well as rapid tests designed for point-of-care use.

The company serves hospitals, clinical laboratories, blood banks, physician offices, and other healthcare providers. Its product lines include the VITROS clinical laboratory systems, ORTHO VISION blood-bank analyzers, and Sofia rapid diagnostic platforms.

QuidelOrtho was formed through the combination of Quidel Corporation and Ortho Clinical Diagnostics, which completed their merger in 2022. The company serves customers in the United States and internationally.

AI Generated. May Contain Errors.

QuidelOrtho Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

QDEL MarketRank™: 
3.155269720435 of 5 stars

QuidelOrtho scored higher than 63% of companies evaluated by MarketBeat, and ranked 332nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    QuidelOrtho has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 2 sell ratings.

  • Upside Potential

    QuidelOrtho has a consensus price target of $13.63, representing about 26.9% upside from its current price of $10.74.

  • Amount of Analyst Coverage

    QuidelOrtho has only been the subject of 2 research reports in the past 90 days.

  • Read more about QuidelOrtho's stock forecast and price target.
  • Earnings Growth

    Earnings for QuidelOrtho are expected to grow by 100.00% in the coming year, from $0.66 to $1.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of QuidelOrtho is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of QuidelOrtho is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    QuidelOrtho has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    21.32% of the float of QuidelOrtho has been sold short.
  • Short Interest Ratio / Days to Cover

    QuidelOrtho has a short interest ratio ("days to cover") of 7.6.
  • Change versus previous month

    Short interest in QuidelOrtho has recently increased by 11.34%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    QuidelOrtho does not currently pay a dividend.

  • Dividend Growth

    QuidelOrtho does not have a long track record of dividend growth.

  • News Sentiment

    QuidelOrtho has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for QuidelOrtho this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for QDEL on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added QuidelOrtho to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, QuidelOrtho insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.10% of the stock of QuidelOrtho is held by insiders.

  • Percentage Held by Institutions

    99.00% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about QuidelOrtho's insider trading history.
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QDEL Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 9.2% - What's Next?
See More Headlines

QDEL Stock Analysis - Frequently Asked Questions

QuidelOrtho's stock was trading at $28.56 at the beginning of 2026. Since then, QDEL shares have decreased by 62.4% and is now trading at $10.74.

QuidelOrtho Corporation (NASDAQ:QDEL) released its quarterly earnings data on Tuesday, November, 3rd. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.18 by $0.13. QuidelOrtho's revenue for the quarter was down 11.6% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of QuidelOrtho include State Street Corp (4.41%), Private Management Group Inc. (3.34%), Gagnon Securities LLC (1.89%) and Skylands Capital LLC (0.85%). Insiders that own company stock include Brian J Blaser, Matthew Strobeck, Ann D Rhoads, Joseph D Jr Wilkins, Joseph M Busky and Carlyle Group Inc.
View institutional ownership trends
.

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that QuidelOrtho investors own include NVIDIA (NVDA), Tesla (TSLA), Zoom Communications (ZM), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (XYZ) and Docusign (DOCU).

Company Calendar

Last Earnings
11/03/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:QDEL
CIK
1906324
Employees
6,500
Year Founded
1979

Price Target and Rating

High Price Target
$18.00
Low Price Target
$12.00
Potential Upside/Downside
+26.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.14
P/E Growth
N/A
Net Income
-$1.13 billion
Net Margins
-14.24%
Pretax Margin
-12.96%
Return on Equity
3.22%
Return on Assets
1.03%

Debt

Debt-to-Equity Ratio
1.40
Current Ratio
1.36
Quick Ratio
0.75

Sales & Book Value

Annual Sales
$2.73 billion
Price / Sales
0.27
Cash Flow
$19.18 per share
Price / Cash Flow
0.56
Book Value
$26.11 per share
Price / Book
0.41

Miscellaneous

Outstanding Shares
68,610,000
Free Float
67,858,000
Market Cap
$736.87 million
Optionable
Optionable
Beta
0.77

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:QDEL) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners